Kamel I - Search Results

1

Integrated immunological analysis of a successful conversion of locally advanced hepatocellular carcinoma to resectability with neoadjuvant therapy.

Ho WJ, Sharma G, Zhu Q, Stein-O'Brien G, Durham J, Anders R, Popovic A, Mo G, Kamel I, Weiss M, Jaffee E, Fertig EJ, Yarchoan M. Ho WJ, et al. Among authors: kamel i. J Immunother Cancer. 2020 Nov;8(2):e000932. doi: 10.1136/jitc-2020-000932. J Immunother Cancer. 2020. PMID: 33219090 Free PMC article.

2

Imaging evaluation of hepatocellular carcinoma.

Kamel IR, Bluemke DA. Kamel IR, et al. J Vasc Interv Radiol. 2002 Sep;13(9 Pt 2):S173-84. doi: 10.1016/s1051-0443(07)61784-9. J Vasc Interv Radiol. 2002. PMID: 12354834 Review.

3

Multidetector CT of hepatocellular carcinoma.

Kamel IR, Liapi E, Fishman EK. Kamel IR, et al. Best Pract Res Clin Gastroenterol. 2005 Feb;19(1):63-89. doi: 10.1016/j.bpg.2004.10.005. Best Pract Res Clin Gastroenterol. 2005. PMID: 15757805 Review.

4

Differences in characteristics of patients with and without known risk factors for hepatocellular carcinoma in the United States.

Dorfman JD, Schulick R, Choti MA, Geschwind JF, Kamel I, Torbenson M, Thuluvath PJ. Dorfman JD, et al. Among authors: kamel i. World J Gastroenterol. 2007 Feb 7;13(5):781-4. doi: 10.3748/wjg.v13.i5.781. World J Gastroenterol. 2007. PMID: 17278203 Free PMC article.

5

Biopsy considerations in the diagnosis of hepatic masses.

Anders RA, Kamel IR. Anders RA, et al. Clin Gastroenterol Hepatol. 2007 May;5(5):541-4. doi: 10.1016/j.cgh.2007.02.028. Clin Gastroenterol Hepatol. 2007. PMID: 17478344 Review.

6

Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging.

Kamel IR, Liapi E, Reyes DK, Zahurak M, Bluemke DA, Geschwind JF. Kamel IR, et al. Radiology. 2009 Feb;250(2):466-73. doi: 10.1148/radiol.2502072222. Radiology. 2009. PMID: 19188315 Free PMC article.

7

Single-center phase II trial of transarterial chemoembolization with drug-eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States.

Reyes DK, Vossen JA, Kamel IR, Azad NS, Wahlin TA, Torbenson MS, Choti MA, Geschwind JF. Reyes DK, et al. Cancer J. 2009 Nov-Dec;15(6):526-32. doi: 10.1097/PPO.0b013e3181c5214b. Cancer J. 2009. PMID: 20010173 Free PMC article. Clinical Trial.

8

Infiltrating hepatocellular carcinoma: seeing the tree through the forest.

Demirjian A, Peng P, Geschwind JF, Cosgrove D, Schutz J, Kamel IR, Pawlik TM. Demirjian A, et al. J Gastrointest Surg. 2011 Nov;15(11):2089-97. doi: 10.1007/s11605-011-1614-7. Epub 2011 Jul 2. J Gastrointest Surg. 2011. PMID: 21725699 Free PMC article. Review.

9

Hepatocellular carcinoma: response to TACE assessed with semiautomated volumetric and functional analysis of diffusion-weighted and contrast-enhanced MR imaging data.

Bonekamp S, Jolepalem P, Lazo M, Gulsun MA, Kiraly AP, Kamel IR. Bonekamp S, et al. Radiology. 2011 Sep;260(3):752-61. doi: 10.1148/radiol.11102330. Epub 2011 Jul 19. Radiology. 2011. PMID: 21771960

10

Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma.

Pawlik TM, Reyes DK, Cosgrove D, Kamel IR, Bhagat N, Geschwind JF. Pawlik TM, et al. J Clin Oncol. 2011 Oct 20;29(30):3960-7. doi: 10.1200/JCO.2011.37.1021. Epub 2011 Sep 12. J Clin Oncol. 2011. PMID: 21911714 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

531 results

Search Page

Filters